HIV-1 protease is an effective target for designing drugs against AIDS, and structural information about the true transition state and the correct mechanism can provide important inputs. We present here the three-dimensional structure of a bi-product complex between HIV-1 protease and the two cleavage product peptides AETF and YVDGAA. The structure, refined against synchrotron data to 1.65 Å resolution, shows the occurrence of the cleavage reaction in the crystal, with the product peptides still held in the enzyme active site. The separation between the scissile carbon and nitrogen atoms is 2.67 Å, which is shorter than a normal van der Waal separation, but it is much longer than a peptide bond length. The substrate is thus in a stage just past the G'Z intermediate described in Northrop's mechanism [Northrop DB (2001) Acc Chem Res 34:790 -797]. Because the products are generated in situ, the structure, by extrapolation, can give insight into the mechanism of the cleavage reaction. Both oxygens of the generated carboxyl group form hydrogen bonds with atoms at the catalytic center: one to the OD2 atom of a catalytic aspartate and the other to the scissile nitrogen atom. The latter hydrogen bond may have mediated protonation of scissile nitrogen, triggering peptide bond cleavage. The inner oxygen atoms of the catalytic aspartates in the complex are 2.30 Å apart, indicating a low-barrier hydrogen bond between them at this stage of the reaction, an observation not included in Northrop's proposal. This structure forms a template for designing mechanism-based inhibitors.AIDS ͉ catalysis ͉ reaction intermediate ͉ x-ray crystallography H IV-1 protease (PR) is a homodimeric, aspartyl PR containing the signature sequence Asp-Thr-Gly in each monomer. The enzyme, which cleaves the viral polyprotein at eight different sites during the maturation process of the virus, is an important target for structure-based drug design (1-4). Emergence of drug-resistant mutations presents a new challenge, and additional inputs, such as the mechanism and interactions of the active enzyme with plain peptide substrates rather than with analogs, are required to tackle drug resistance. To address this question, we have undertaken to solve the crystal structures of HIV-1 PR oligopeptide substrate complexes. The enzyme used in the present study is a single polypeptide chain where the C terminus of the first monomer is linked with the N terminus of the second monomer through a pentapeptide (-GGSSG-) linker. The enzyme activity of such a tethered dimer (TD) construct is comparable with that of the native homodimer (5). Previously (6, 7), we have reported structures of TD and its complex with the undecapeptide substrate that corresponds in sequence to the reverse transcriptase-integrase junction in the viral polyprotein. Here we report the crystal structure of TD complexed with a decapeptide of amino acid sequence matching the reverse transcriptase-RNase H junction of the polyprotein. The structure has been refined to 1.65 Å resolution against diffra...